Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZTPX3)

Drug Name

CIN-109 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Obesity	5B81	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Preclinical Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Growth/differentiation factor 15 (GDF15)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Ponsegromab	DM5HO2X	Cancer cachexia	MG20.0	Phase 2	[3]
CIN-209	DMBK5CQ	Obesity	5B81	Preclinical	[1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Growth/differentiation factor 15 (GDF15)	TT4MXVG	GDF15_HUMAN	Replacement	[2]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of CinFina Pharma
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight
3	Current advancements in pharmacotherapy for cancer cachexia. Expert Opin Pharmacother. 2023 Apr;24(5):629-639.